STOCK TITAN

[144] ARGAN INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Form 144 Notice — ARGAN INC (AGX) This filing notifies a proposed sale of 4,698 shares of common stock on 09/29/2025 through Charles Schwab & Co., Inc. The filing states the shares were acquired via equity grants and exercised as options on 04/25/2024 (2,402 shares) and 06/12/2024 (2,296 shares). Aggregate market value of the proposed sale is reported as $1,281,708.36 and the total shares outstanding is listed as 13,811,575. The filer also discloses a prior sale of 2,621 shares on 07/29/2025 with gross proceeds of $617,586.23. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Modulo 144 Avviso — ARGAN INC (AGX) Questa dichiarazione segnala una proposta di vendita di 4.698 azioni ordinarie il 29/09/2025 tramite Charles Schwab & Co., Inc. La dichiarazione indica che le azioni sono state acquisite tramite grant di equity e esercitate come opzioni il 25/04/2024 (2.402 azioni) e il 12/06/2024 (2.296 azioni). Il valore di mercato aggregato della vendita proposta è indicato come $1.281.708,36 e il totale delle azioni in circolazione è riportato come 13.811.575. L'inseritore dichiara anche una vendita precedente di 2.621 azioni il 29/07/2025 con proventi lordi di $617.586,23. L'avviso include la dichiarazione richiesta secondo cui il venditore non è a conoscenza di informazioni materialmente avverse non divulgate.

Aviso Formulario 144 — ARGAN INC (AGX) Esta presentación notifica una venta propuesta de 4.698 acciones ordinarias el 29/09/2025 a través de Charles Schwab & Co., Inc. La documentación indica que las acciones se adquirieron mediante otorgamientos de acciones y se ejercieron como opciones el 25/04/2024 (2.402 acciones) y el 12/06/2024 (2.296 acciones). El valor de mercado agregado de la venta propuesta se reporta como $1,281,708.36 y el total de acciones en circulación figura como 13,811,575. El presentante también divulga una venta previa de 2,621 acciones el 29/07/2025 con ingresos brutos de $617,586.23. El aviso incluye la representación requerida de que el vendedor no tiene conocimiento de información adversa material no divulgada.

Form 144 통지 — ARGAN INC (AGX) 본 제출서는 4,698 주식의 매각 제안을 2025-09-29를 통해 Charles Schwab & Co., Inc.로 공지합니다. 제출서에 따르면 주식은 주식 부여를 통해 취득되었고 2024-04-25에 옵션으로 행사되었으며(2,402주) 2024-06-12에(2,296주) 행사되었습니다. 제안된 매각의 총 시장 가치는 $1,281,708.36로 보고되며 발행주식 총수는 13,811,575주로 기재되어 있습니다. 제출자는 또한 2025-07-292,621주를 매각한 이전 거래를 총수익 $617,586.23으로 공시합니다. 본 통지에는 매도인이 비공개된 중요한 악재 정보를 인지하지 못하고 있다는 필수 진술이 포함되어 있습니다.

Formulaire 144 Avis — ARGAN INC (AGX) Cette démarche notifie une vente proposée de 4 698 actions ordinaires le 29/09/2025 via Charles Schwab & Co., Inc. Le document indique que les actions ont été acquises par le biais de attributions d’actions et exercées sous forme d’options le 25/04/2024 (2 402 actions) et le 12/06/2024 (2 296 actions). La valeur marchande agrégée de la vente proposée est indiquée comme $1,281,708.36 et le nombre total d’actions en circulation est inscrit comme 13,811,575. Le déclarant divulge également une vente antérieure de 2,621 actions le 29/07/2025 avec un produit brut de $617,586.23. L’avis comprend la représentation requise selon laquelle le vendeur n’est pas au courant d’informations materialement défavorables non divulguées.

Formular 144 Hinweis — ARGAN INC (AGX) Diese Einreichung informiert über einen vorgeschlagenen Verkauf von 4.698 Stammaktien am 29.09.2025 über Charles Schwab & Co., Inc. Die Unterlage gibt an, dass die Aktien durch Aktienzuteilungen erworben und als Optionen am 25.04.2024 (2.402 Aktien) bzw. am 12.06.2024 (2.296 Aktien) ausgeübt wurden. Der aggregierte Marktwert des vorgeschlagenen Verkaufs wird mit $1.281.708,36 angegeben und die insgesamt ausstehenden Aktien werden mit 13.811.575 beziffert. Der Melder gibt außerdem einen früheren Verkauf von 2.621 Aktien am 29.07.2025 mit Bruttoerlösen von $617.586,23 bekannt. Die Anzeige enthält die erforderliche Bestätigung, dass der Verkäufer über keine nicht offengelegten wesentlichen nachteiligen Informationen verfügt.

إشعار النموذج 144 — آرغان إنك (AGX) يعلِم هذا الإيداع ببيع مقترح لـ 4,698 سهماً من الأسهم العادية في 29/09/2025 عن طريق Charles Schwab & Co., Inc. وتذكر الإيداع أن الأسهم تم الحصول عليها من خلال منح الأسهم ومُتَّم اتخاذها كخيار في 25/04/2024 (2,402 سهماً) و 12/06/2024 (2,296 سهماً). تُذكر القيمة السوقية الإجمالية للبيع المقترح بمبلغ $1,281,708.36 كما يُدرج إجمالي الأسهم القائمة على أنه 13,811,575. كما يكشف الملف عن بيع سابق لـ 2,621 سهماً في 29/07/2025 بإيرادات إجمالية قدرها $617,586.23. يتضمن الإشعار التمثيل المطلوب بأن البائع غير على علم بمعلومات سلبية جوهرية غير مُعلنة.

Form 144 通知 — ARGAN INC(AGX) 本次备案通知通过 Charles Schwab & Co., Inc. 计划出售 4,698 股普通股,日期为 2025/09/29。备案称这些股份是通过 股票授予 获得并在 2024/04/25(2,402 股)和 2024/06/12(2,296 股)以期权方式行使。拟议出售的聚合市场价值被报为 $1,281,708.36,流通股总数列为 13,811,575 股。备案人还披露此前在 2025/07/29 出售 2,621 股,毛收入为 $617,586.23。通知包含所需的陈述,即卖方并不知悉尚未披露的重大不利信息。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider filing discloses option-exercised shares and a planned smallblock sale; not obviously material to company capitalization.

The filer reports an upcoming sale of 4,698 shares acquired via equity grants and option exercises, with an aggregate market value of $1,281,708.36. Given the stated 13,811,575 shares outstanding, the notice documents routine insider liquidity rather than a large disposition. The filing also lists a prior sale of 2,621 shares for $617,586.23. These disclosures meet Rule 144 notice requirements and provide transparency about the source of the shares (issuer equity grants and option exercises) and the broker used.

TL;DR: The filing documents compliance with Rule 144 for an insider sale arising from equity compensation; procedural rather than governance-negative.

The notice indicates the securities were acquired from the issuer via equity grants and exercised by option on specified dates, and the seller affirms no undisclosed material adverse information. The use of a trading broker and the inclusion of a recent prior sale show adherence to public-disclosure norms for insider transactions. There is no information here indicating unusual governance concerns.

Modulo 144 Avviso — ARGAN INC (AGX) Questa dichiarazione segnala una proposta di vendita di 4.698 azioni ordinarie il 29/09/2025 tramite Charles Schwab & Co., Inc. La dichiarazione indica che le azioni sono state acquisite tramite grant di equity e esercitate come opzioni il 25/04/2024 (2.402 azioni) e il 12/06/2024 (2.296 azioni). Il valore di mercato aggregato della vendita proposta è indicato come $1.281.708,36 e il totale delle azioni in circolazione è riportato come 13.811.575. L'inseritore dichiara anche una vendita precedente di 2.621 azioni il 29/07/2025 con proventi lordi di $617.586,23. L'avviso include la dichiarazione richiesta secondo cui il venditore non è a conoscenza di informazioni materialmente avverse non divulgate.

Aviso Formulario 144 — ARGAN INC (AGX) Esta presentación notifica una venta propuesta de 4.698 acciones ordinarias el 29/09/2025 a través de Charles Schwab & Co., Inc. La documentación indica que las acciones se adquirieron mediante otorgamientos de acciones y se ejercieron como opciones el 25/04/2024 (2.402 acciones) y el 12/06/2024 (2.296 acciones). El valor de mercado agregado de la venta propuesta se reporta como $1,281,708.36 y el total de acciones en circulación figura como 13,811,575. El presentante también divulga una venta previa de 2,621 acciones el 29/07/2025 con ingresos brutos de $617,586.23. El aviso incluye la representación requerida de que el vendedor no tiene conocimiento de información adversa material no divulgada.

Form 144 통지 — ARGAN INC (AGX) 본 제출서는 4,698 주식의 매각 제안을 2025-09-29를 통해 Charles Schwab & Co., Inc.로 공지합니다. 제출서에 따르면 주식은 주식 부여를 통해 취득되었고 2024-04-25에 옵션으로 행사되었으며(2,402주) 2024-06-12에(2,296주) 행사되었습니다. 제안된 매각의 총 시장 가치는 $1,281,708.36로 보고되며 발행주식 총수는 13,811,575주로 기재되어 있습니다. 제출자는 또한 2025-07-292,621주를 매각한 이전 거래를 총수익 $617,586.23으로 공시합니다. 본 통지에는 매도인이 비공개된 중요한 악재 정보를 인지하지 못하고 있다는 필수 진술이 포함되어 있습니다.

Formulaire 144 Avis — ARGAN INC (AGX) Cette démarche notifie une vente proposée de 4 698 actions ordinaires le 29/09/2025 via Charles Schwab & Co., Inc. Le document indique que les actions ont été acquises par le biais de attributions d’actions et exercées sous forme d’options le 25/04/2024 (2 402 actions) et le 12/06/2024 (2 296 actions). La valeur marchande agrégée de la vente proposée est indiquée comme $1,281,708.36 et le nombre total d’actions en circulation est inscrit comme 13,811,575. Le déclarant divulge également une vente antérieure de 2,621 actions le 29/07/2025 avec un produit brut de $617,586.23. L’avis comprend la représentation requise selon laquelle le vendeur n’est pas au courant d’informations materialement défavorables non divulguées.

Formular 144 Hinweis — ARGAN INC (AGX) Diese Einreichung informiert über einen vorgeschlagenen Verkauf von 4.698 Stammaktien am 29.09.2025 über Charles Schwab & Co., Inc. Die Unterlage gibt an, dass die Aktien durch Aktienzuteilungen erworben und als Optionen am 25.04.2024 (2.402 Aktien) bzw. am 12.06.2024 (2.296 Aktien) ausgeübt wurden. Der aggregierte Marktwert des vorgeschlagenen Verkaufs wird mit $1.281.708,36 angegeben und die insgesamt ausstehenden Aktien werden mit 13.811.575 beziffert. Der Melder gibt außerdem einen früheren Verkauf von 2.621 Aktien am 29.07.2025 mit Bruttoerlösen von $617.586,23 bekannt. Die Anzeige enthält die erforderliche Bestätigung, dass der Verkäufer über keine nicht offengelegten wesentlichen nachteiligen Informationen verfügt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

3.74B
13.27M
4.48%
89.2%
5.37%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON